GlassScriptPhysician profile
Meredith T Beck
NPI 1679978357
$1,530.77
in general payments reported to CMS, 2019-2025
18 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $257 · 2023: $423 · 2024: $374 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.85 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $408.21 | 2021-2025 | Interstim |
| Astrazeneca Pharmaceuticals LP | $344.83 | 2021-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $126.57 | 2023-2025 | |
| Boston Scientific Corporation | $126.45 | 2024-2025 | Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $95.40 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.50 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $49.68 | 2024-2025 | Ojjaara, Blenrep |
| Daiichi Sankyo INC. | $42.36 | 2023 | Injectafer |
| Abbott Laboratories | $40.01 | 2024-2025 | Esprit |
| E.R. Squibb & Sons, L.L.C. | $37.73 | 2021-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $34.62 | 2023-2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $32.90 | 2024 | Arcalyst |
| Amgen INC. | $31.86 | 2024-2025 | Repatha |
| Actelion Pharmaceuticals US, INC. | $26.36 | 2025 | Uptravi, Opsumit |
| Scpharmaceuticals INC. | $18.08 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.23 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.07 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.91 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.